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The objective of this study was to examine exercise effects on global brain volume, hippocampal
volume, and cortical thickness in schizophrenia patients and healthy controls. Irrespective of
diagnosis and intervention, associations between brain changes and cardiorespiratory ﬁtness
improvement were examined. Sixty-three schizophrenia patients and ﬁfty-ﬁve healthy controls
participated in this randomised controlled trial. Global brain volumes, hippocampal volume, and
cortical thickness were estimated from 3-Tesla MRI scans. Cardiorespiratory ﬁtness was assessed
with a cardiopulmonary ergometer test. Subjects were assigned exercise therapy or occupational
therapy (patients) and exercise therapy or life-as-usual (healthy controls) for six months 2 h weekly.
Exercise therapy effects were analysed for subjects who were compliant at least 50% of sessions
offered. Signiﬁcantly smaller baseline cerebral (grey) matter, and larger third ventricle volumes,
and thinner cortex in most areas of the brain were found in patients versus controls. Exercise
therapy did not affect global brain and hippocampal volume or cortical thickness in patients and
controls. Cardiorespiratory ﬁtness improvement was related to increased cerebral matter volume
and lateral and third ventricle volume decrease in patients and to thickening in the left hemisphere
in large areas of the frontal, temporal and cingulate cortex irrespective of diagnosis. One to 2 h of
exercise therapy did not elicit signiﬁcant brain volume changes in patients or controls. However,
cardiorespiratory ﬁtness improvement attenuated brain volume changes in schizophrenia patientsElsevier B.V. and ECNP. All rights reserved.
o.2012.08.008
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T.W. Scheewe et al.676and increased thickness in large areas of the left cortex in both schizophrenia patients and healthy
controls.
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In schizophrenia, structural brain abnormalities, in particular
smaller grey matter volume, enlargement of lateral and third
ventricles, decreased hippocampal volume, and cortical thin-
ning have consistently been demonstrated (Hulshoff Pol et al.,
2002; Shenton et al., 2001; Wright et al., 2000). Longitudinal
studies have shown that these brain volume abnormalities are
progressive in nature (Olabi et al., 2011), not only in the early
phases of the illness (Pantelis et al., 2005) but also in chronic
stages (Hulshoff Pol and Kahn, 2008; Kempton et al., 2010).
These changes are related to the clinical course as several
studies have shown that patients with poorest outcome have
most pronounced brain loss over time (Cahn et al., 2009;
Hulshoff Pol and Kahn, 2008; Pantelis et al., 2005; van Haren
et al., 2008a). To explain these progressive brain volume
reductions in schizophrenia, researchers have suggested that
these reductions are core to the illness and could be due to
the so-called ‘‘toxic’’ effects of the psychotic state of the
brain (Lieberman et al., 2001; McGlashan, 2006; Seok et al.,
2005). Some evidence has been provided by the ﬁndings of a
ﬁve year follow-up MRI study which found longer duration of
psychosis during follow-up was associated with more pro-
nounced grey matter volume reductions and increases of
ventricular volume (Cahn et al., 2009). In addition, it has
been shown that genetic factors play a role in the progressive
brain volume reductions in schizophrenia patients (Brans
et al., 2008; Gogtay et al., 2007). Nevertheless, others have
argued that volume decrease over time originates from
(unhealthy) environmental factors patients with schizophrenia
are frequently exposed to (Mathalon et al., 2003; Moncrieff
and Leo, 2010; Navari and Dazzan, 2009; Rais et al., 2008,
2010; van Haren et al., 2011).
Indeed, alcohol abuse (Mathalon et al., 2003), cannabis use
(Rais et al., 2008, 2010), and antipsychotic treatment (Moncrieff
and Leo, 2010; Navari and Dazzan, 2009; van Haren et al., 2011)
have been found to inﬂuence brain changes over time in
schizophrenia. Furthermore, physical inactivity (Lindamer
et al., 2008) and poor cardiorespiratory ﬁtness (Strassnig
et al., 2011) could also explain brain volume reductions seen
in schizophrenia. If physical inactivity and poor cardiorespiratory
ﬁtness explain the brain volume reductions in schizophrenia,
one would expect that the brain volume decreases will diminish
when cardiorespiratory ﬁtness increases. Interestingly, animal
studies have unequivocally shown that physical exercise posi-
tively affects brain morphology, especially in the hippocampus,
and brain functioning (van Praag, 2008, 2009). In healthy
elderly, studies have shown that exercise increases cerebral
grey and white matter (Colcombe et al., 2006) and hippocampal
volumes (Erickson et al., 2011). As far as we know only one
neuroimaging study has been performed examining the effects
of exercise in schizophrenia (Pajonk et al., 2010). They
examined the hippocampal volume and found hippocampus
volume enlargement after three months of exercise in male
patients (n=8). Moreover, this increase was related tocardiorespiratory ﬁtness improvement (Pajonk et al., 2010).
They did not examine the effects on global brain volume nor on
cortical thickness.
This study examines the effect of exercise therapy on
global brain volume, hippocampus, and cortical thickness in
schizophrenia patients and healthy controls. Since we
recently showed that exercise therapy in schizophrenia
improves cardiorespiratory ﬁtness, in particular peak work-
load (measured as Wpeak) (Scheewe et al., 2012) we also
investigated the association between changes in global
brain volumes, hippocampus and cortical thickness and
change in cardiorespiratory ﬁtness.2. Experimental procedures
2.1. Sample and setting
This multicentre study included 63 patients with a schizophrenia
spectrum disorder and 55 healthy controls, matched for gender, age,
and socioeconomic status of their parents (expressed as highest
educational level of one of the parents). Patients were recruited at
the University Medical Center Utrecht (The Netherlands), the
Institute for Mental Health Care Altrecht (Utrecht, The Netherlands),
GGZ Duin- en Bollenstreek (Voorhout, The Netherlands), and GGZ
Friesland (Heerenveen, The Netherlands). Participants were enroled
in the study between May 2007 and May 2010 and written informed
consent was obtained after the procedures and possible side effects
were explained. After baseline measurement, a computer-generated
randomisation procedure, incorporating concealed allocation (ratio
1:1), was performed with stratiﬁcation for gender, recruitment site
and Body Mass Index (BMI; below or above critical 25). Patients were
assigned to exercise therapy or occupational therapy whereas
controls were assigned to exercise therapy or life as usual for six
months. Patients had a diagnosis of schizophrenia (n=45), schizoaf-
fective (n=15) or schizophreniform disorder (n=3) according to the
Diagnostic and Statistical Manual of Mental Disorders, fourth edition
(DSM-IV) (American Psychiatri Association, 2000). Diagnosis was
conﬁrmed by psychiatrists using the Comprehensive Assessment of
Schizophrenia and History (CASH) (Andreasen et al., 1992). Patients
were stable on antipsychotic medication, i.e. using the same dosage
for at least four weeks prior to inclusion. They showed no evidence
for signiﬁcant cardiovascular, neuromuscular, endocrine or other
somatic disorders that prevented safe participation in the study
(IOC Medical Commission, 2004). Patients did not have a primary
diagnosis of alcohol or substance abuse and had an IQZ70, as
measured with the Wechsler Adult Intelligence Scale Short Form
(WAIS-III SF) (Christensen et al., 2007).
Healthy participants were recruited via advertisements from the
local population. The inclusion criteria for the healthy controls
were an age between 18 and 48 years, no diagnosis of psychiatric
disorders according to DSM-IV lifetime (American Psychiatric
Association, 2000), no ﬁrst-degree relative with a psychotic or
depressive disorder, and being physically inactive before inclusion
(i.e., undertaking less than 1 h of moderate physical activity
weekly).
The study was approved by the Human Ethics Committee of the
University Medical Center Utrecht and research committees of
participating centres.
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All subjects underwent a six months intervention. Demographic and
clinical baseline and follow-up measurements were assessed by a
research assistant and sports physician blind to randomisation. All
assessments at baseline and follow-up were acquired within a time
frame of 14 days.
2.2.1. Cardiorespiratory ﬁtness testing
Cardiorespiratory ﬁtness (CRF) was assessed with a cardiopulmonary
exercise test (CPET), performed using a 20 W per minute (W/min)
stepwise incremental protocol to exhaustion on a cycle ergometer
(Lode Excalibur, Lode BV, Groningen, the Netherlands) (Godfrey,
1974). CRF was deﬁned as the peak work rate at the moment of
exhaustion (Wpeak in wattage (W)) (Astorino, 2009). Heart rate
(twelve led ECG) and oxygen uptake were measured continuously
during the CPET (MetaLyzers 3B, Cortex Medical GmbH, Leipzig,
Germany). Maximal efforts were assumed when the respiratory
exchange rate (RER) equalled or exceeded 1.1 (Doherty et al.,
2003).
2.2.2. Symptom severity and medication
To evaluate severity of symptoms, the Positive and Negative
Syndrome Scale (PANSS) total score was assessed in patients (Kay
et al., 1988). Information on amount, type and compliance of
prescribed antipsychotic and other medication was gathered for
lifetime, at baseline and monthly between baseline and six months.
Antipsychotics are described in cumulative dosage (up to baseline
and baseline to follow-up) and converted into haloperidol equiva-
lents (clozapine, 40:1; olanzapine, 2.5:1; risperidone, 1:1; aripi-
prazole, 3.75:1; quetiapine, 50:1; pimozide, 0.85:1; pipamperon,
50:1; penﬂuridol, 1:1; broomperidol, 1:1; zuclopentixol, 5:1;
haloperidol, 1:1 in conformance with a table from the Dutch
National Health Service) (Commissie Farmaceutische Hulp, 2002).
Detailed information on medication prescription and compliance
was assessed monthly by the research assistant.
2.2.3. Imaging and preprocessing
Structural MRI scans of the whole brain were acquired on a single
3 T Achieva medical scanner (Philips, Best, The Netherlands).
A three dimensional (3D) anatomical T1-weighted image of the
whole head was acquired (Fast Field Echo (FFE) using parallel
imaging; 180 0.8-mm contiguous sagittal slices, echo time [TE]=4.6
ms, repetition time [TR]=10 ms, ﬂip angle=901, Field of View
(FOV)=240 mm/100%, in-plane voxel size 0.75 0.75 mm2, recon-
struction matrix=200 320 320). Volumetric processing was per-
formed on the computer network of the Department of Psychiatry
of the Brain Division, University Medical Center Utrecht, The
Netherlands. All brain images were coded to ensure investigator
blindness to subject identiﬁcation.
2.2.4. Volumetric processing
The T1-weighted images were automatically placed in Talairach
orientation (Talairach and Tournoux, 1988) without scaling, by
registering them to a model brain. Intracranial masks were created
by registration from the T1-weighted image to a model brain using
an iterative process of non-linear transformations with increasing
precision up to voxel resolution. This model brain was created from
an independent group of schizophrenia patients, their siblings and
healthy controls (Boos et al., 2011) following a similar procedure as
described previously (Peper et al., 2008). Intracranial masks were
manually edited, where necessary. The intracranial segment served
as a mask for all further segmentation steps. The T1-weighted
images were corrected for ﬁeld inhomogeneities using the N3
algorithm (Sled et al., 1998). An automatic image-processing pipe-
line was used to deﬁne the volume of the cerebrum, cerebral grey
matter and white matter (Brouwer et al., 2010). In short, pure greyand white matter intensities were directly estimated from the
image. The amounts of pure and partial volume voxels were
modelled in a non-uniform partial volume density, which is ﬁtted
to the intensity histogram. Expected tissue fractions, based on the
pure intensities and the partial volume density, were subsequently
computed in each voxel within the cerebrum. Total brain volume
was calculated by adding the grey and white matter volumes.
Lateral and third ventricle volumes were also assessed. The soft-
ware included histogram analysis, mathematical morphology opera-
tions, and anatomical knowledge-based rule to connect all voxels of
interest, as was validated before (Schnack et al., 2001). The
segments for lateral and third ventricles were visually checked
and edited to ensure an accurate segmentation.
2.2.5. Hippocampus volume
Measurement of hippocampal volume was done using automated
hippocampal volume methodology (FMRIB software library, FSL 4.1).
Hippocampi were automatically labelled using the subcortical
segmentation routines ‘‘FIRST,’’ provided as part of the FSL soft-
ware distribution (version 4.1.2, http://www.fmrib.ox.ac.uk/fsl/).
Before starting the FSL-FIRST-based segmentation the T1-weighted
images were automatically placed in Talairach orientation as described
earlier. The initial step for FSL-FIRSTwas an afﬁne registration of each
brain to MNI-152 space (Mazziotta et al., 2001). The correct afﬁne
registration was visually conﬁrmed in all cases. The number of modes
of variation for the hippocampal template to be warped to ﬁt the
individual hippocampi was set to 300. Each automatically segmented
hippocampus was saved as an inclusive binary mask in the same space
as the original image. The volumes of right and left hippocampi were
extracted. See also ENIGMA Consortium protocols, http://enigma.loni.
ucla.edu/protocols/.
2.2.6. Cortical thickness
To estimate cortical thickness, we used the CLASP (Constrained
Laplacian Anatomic Segmentation Using Proximity) algorithm
designed at the McConnell Brain Imaging Centre of the Montreal
Neurological Institute (Kabani et al., 2001; Kim et al., 2005;
MacDonald et al., 2000). A 3-dimensional surface consisting of
81,920 polygons was ﬁtted to the white matter–grey matter inter-
face. This deﬁned the inner surface of the cortex, which was then
expanded to ﬁt the grey matter–cerebrospinal ﬂuid interface,
thereby creating the outer cortical surface (Kim et al., 2005;
MacDonald et al., 2000). Cortical thickness was estimated by taking
the distance between the two surfaces; thus, each polygon vertex
on the outer surface had a counterpart vertex on the inner surface.
The surfaces of both measurements for each participant were
registered to an average surface created from 152 individuals
(Lyttelton et al., 2007), allowing comparison of cortical thickness
locally between participants at baseline and the follow-up mea-
surement. Region-of-Interests (ROIs) were automatically segmented
using the automated anatomical labelling (AAL) atlas (Tzourio-
Mazoyer et al., 2002), resulting in 78 ROIs (39 for both left and
right hemispheres). For each person, the change in cortical thick-
ness was calculated for each of the AAL areas.
2.3. Intervention
The exercise therapy intervention was designed to improve CRF and
primarily incorporated cardiorespiratory exercises. Cardiorespira-
tory exercises were performed using the following exercise equip-
ment: upright bicycle ergometer, recumbent bicycle ergometer,
rowing machine, cross-trainer, and treadmill. In addition, muscle
strength exercises (six exercises per week; three times 10–15
repetitions maximum for biceps, triceps, abdominal, quadriceps,
pectoral, deltoid muscles) were included to provide variation. The
programme followed the recommendations of the American College
of Sports Medicine (American College of Sports Medicine, 1998;
T.W. Scheewe et al.678Kraemer et al., 2002). Exercise therapy was supervised by a
psychomotor therapist specialised in psychiatry. Information on
amount of training and compliance was registered in a logbook.
Exercise therapy subjects were prescribed an hour of exercise,
consisting of both cardiovascular exercises (40 min) and muscle
strength exercises (20 min) twice weekly for six months. To prevent
dropout of patients due to injury and exhaustion, exercise intensity
was increased stepwise (week 1–3: 45%; week 4–12: 65%; week 13–26:
75% of heart rate reserve based on baseline CPET) (American College
of Sports Medicine, 1998).
Patients not randomised to physical therapy were offered
occupational therapy by an occupational therapist 1 h twice weekly
for six months. Occupational therapy comprised creative and
recreational activities. Compared to exercise therapy, occupational
therapy provided a similar amount of structure and attention, but
no physical activation.
2.4. Statistical analysis
SPSS 18.0.1 was used to analyse the demographic and brain volume
data. All statistical tests were performed two-tailed and a p-value of
o0.05 was considered signiﬁcant. Data were examined for outliers.
Analyses were performed with and without outliers to examine their
impact on the results. In case of non-normal distribution logarithmic
transformation was applied, or non-parametric testing was performed.
Previously, exercise therapy was found to reduce symptom
severity (Marzolini et al., 2009) and increase hippocampal volume
in schizophrenia patients (Pajonk et al., 2010). Moreover, para-
hippocampal gyrus growth was only seen in schizophrenia patients
with a higher intelligence (Brans et al., 2010). In case of signiﬁcant
brain volume change results, PANSS total change, antipsychotic
medication used between baseline and follow-up (in haloperidol
equivalent), and intelligence were added to analyses to investigate
whether these factors explain results.
All analyses were performed in those subjects who were
compliant at least 50% of 52 sessions, unless stated otherwise.
The minimal compliance demand is chosen since a minimal work-
load of at least 1 h weekly is needed to be able to expect any effect
in untrained subjects (Kraemer et al., 2002)
2.4.1. Baseline comparisons
Multiple analyses of variance for non-categorical variables and
w2 analyses for categorical variables were used to examine differ-
ences between groups in demographics and clinical characteristics.
Univariate analyses were used to examine baseline brain volume
differences between patients and controls and between exercise
therapy and occupational therapy/life-as-usual. For measures of
cortical thickness, regression analyses were used, with gender, age
and handedness as covariates to investigate main effects for group,
intervention and the interaction between group and intervention.
2.4.2. Brain volume change
Brain volume change was calculated by subtracting baseline volume
from follow-up volume. To assess the differential effect of inter-
vention (exercise therapy versus occupational therapy/life-as-
usual) on brain volume (change) between the groups multiple linear
regression analyses were performed. For cerebrum, cerebral grey
and white matter, lateral and third ventricles, and hippocampal
volume, change was added as the dependent variable in analyses.
Group (patient or control), intervention (exercise therapy or
occupational therapy/life-as-usual), and the group intervention
interaction were the independent variables. Intracranial volume,
gender, and age were included as covariates.
For cortical thickness, regression analyses were used with age,
gender, and handedness as covariates, to examine change in
thickness per AAL region. This produced F statistics at each AAL
region for the effect of group (patient versus controls), intervention(exercise therapy versus occupational therapy/life-as-usual), and
group intervention. We adjusted for multiple comparisons using a
False Discovery Rate (FDR=0.05, two-tailed) (Genovese et al.,
2002). In addition, mean cortical thickness change in each hemi-
sphere was investigated using regression analyses, using the same
covariates.
2.4.3. Effect CRF change on brain volume
Previously, we showed that Wpeak improved after exercise therapy
compared to occupational therapy in patients with schizophrenia
(Scheewe et al., 2012). We therefore performed further analyses to
examine whether an increased CRF ameliorated brain volume
deterioration in patients with schizophrenia and investigated
whether this effect is seen in healthy controls, independent of
intervention. To assess the effect of CRF change on brain volume
(change) multiple linear regression analyses were performed on all
included subjects with two successful scans (so not using the 50%
compliance criterium). For cerebrum, cerebral grey and white
matter, lateral and third ventricles, hippocampal volume, and
cortical thickness, change was the dependent variable in analyses.
Group (patient or control), CRF-change, measured as Wpeak-change,
and an interaction groupWpeak-change were the independent
variables. Intracranial volume, gender and age were included as
covariates when investigating brain volume change. Handedness,
gender and age were included as covariates when investigating
cortical thickness change.
3. Results
In total, 31 patients were randomised to exercise therapy
and 32 patients to occupational therapy, whereas 27 healthy
controls were randomised to exercise therapy and 28 to life-
as-usual (see study diagram in Figure 1). Diagnostic sub-
groups were equally distributed between exercise therapy
(schizophrenia: n=24; schizoaffective disorder: n=6; schi-
zophreniform disorder: n=1) and occupational therapy
patients (schizophrenia: n=21; schizoaffective disorder:
n=9; schizophreniform disorder: n=2; w2(4)=1.67, p=
0.80). Drop-out of patients was signiﬁcantly higher in the
occupational therapy (n=7) compared to the exercise
therapy group (n=2, w2(2)=8.33, p=0.02).
Mean number of attended sessions did not differ signiﬁ-
cantly between exercise therapy patients (mean7SD;
4178), exercise therapy controls (4477), and occupational
therapy patients (4377; F(2,58)=1,37, p=0.26). Detailed
baseline demographic and clinical data are depicted in
Table 1.
3.1. Baseline volumes
After controlling for age, gender, and intracranial volume,
patients had signiﬁcantly lower baseline volumes of the
cerebrum (F(1,77)=0.763, p=0.007), cerebral grey matter
(F(1,77)=10.95, p=0.001), and higher baseline volumes of
the third ventricle (F(1,77)=8.14, p=0.006). In addition, the
mean cortical thickness in each hemisphere was signiﬁcantly
smaller in patients as compared with controls (left:
F(1,77)=17.69, po0.001; right: F(1,77)=12.64, p=0.001)
(see Table 2). Locally, the cortex was thinner in almost all
parts of the brain in patients relative to controls, reaching
signiﬁcance (FDR corrected: right po0.030 and left
po0.036) in 26 out of 39 ROIs in the right hemisphere and
33 out of 39 ROIs in the left hemisphere. No signiﬁcant
63 schizophrenia patients 
included
Completed study
Compliance not taken 
into account
n=28 (EX)
50% compliance
Included in analyses:
n=18 (EX)
Included in Wpeak
change analyses:
n=28 (EX)
Completed study
Compliance not taken 
into account
n=23 (OT)
50% compliance
Included in analyses:
n=16 (OT)
Inlcuded in Wpeak 
change anayses:
n=23 (OT)
n=2 drop out (EX)
n=7 drop out (OT)
n=3 no MRI 
(claustrofobia, 
movement artifacts)
55 healthy controls 
included
Completed study
Compliance not taken 
into account
n=26 (EX)
50% compliance
Included in anayses:
n=25 (EX)
85% compliance
Included in anayses:
n=26 (EX)
Completed study
Included in analyses:
n=27 (LaU)
n=1 drop out (LaU)
n=1 no MRI (movement 
artifacts)
Figure 1 Study diagram for exercise therapy (EX) and occupational therapy (OT) patients, EX and life as usual (LaU) controls.
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0.11, p=0.74), hippocampus (F(1,76)=0.67, p=0.42), and
lateral ventricles (F(1,77)=1.97, p=0.17) were found (see
Table 2). No differences were found in brain volumes and
cortical thickness at baseline between those patients assigned
to exercise versus occupational therapy or in controls assigned
to exercise therapy versus life-as-usual.
3.2. Brain volume change
No signiﬁcant main effect for group or intervention nor
interaction effects between the two were found for change
in cerebral, cerebral grey and white matter, lateral and third
ventricle volume (see Table 2). For change in hippocampal
volume, group or intervention effects were not signiﬁcant, the
interaction effect reached trend level signiﬁcance (p=0.05).
In schizophrenia patients, hippocampal volume decreased
slightly after exercise therapy with no change after occupa-
tional therapy; the opposite effect was observed in healthy
controls. No signiﬁcant main effect for group or intervention
nor an interaction effect was found for change in cortical
thickness. Thus, exercise therapy, once to twice a week for 1 h
during six months did not increase global brain volume,
hippocampal volume, or cortical thickness in schizophrenia
patients or healthy controls.
3.3. Effect CRF change on brain volume
For this analysis all individuals who had two MRI scans
and two CRF measures were included. Interaction effects
between CRF improvement and group were found. CRF
improvement was signiﬁcantly related to cerebral matter
volume increase (0.164 ml/W; p=0.045), lateral ventricle
(0.018 ml/W; p=0.035) and third ventricle volume
decrease (0.0018 ml/W; p=0.013) in patients but not inhealthy controls (cerebral matter: 0.001 ml/W; p=0.990;
lateral ventricle volume: 0.002 ml/W; p=0.745; third ven-
tricle volume: 0.0003 ml/W; p=0.510; see Table 3 and
Figure 2). CRF improvement was, at trend-level signiﬁ-
cance, related to increase in cerebral grey matter
(0.159 ml/W; p=0.059) in patients but not in healthy
controls (cerebral grey matter: 0.019 ml/W; p=0.763;
see Table 3). Exclusion of outliers did not change ﬁndings
except for lateral ventricle volume where exclusion of one
outlier led to a trend-level signiﬁcant effect of CRF
improvement (0.013 ml/W; p=0.078). Addition of symp-
tom severity (PANSS total) change, antipsychotic medication
use, and intelligence as covariates in the analyses had no
inﬂuence on these results. In addition, CRF improvement
was signiﬁcantly associated with thickening (or less thin-
ning) in the left hemisphere only (t42.29, po0.024 after
FDR correction), in large parts of the frontal, temporal and
cingulate cortex (see Figure 3). In the right hemisphere all
but four t-values were positive as well, indicating a
thickening of the cortex (or less thinning) being associated
with an increase in CRF, but none of the areas reached
signiﬁcance. For cortical thickness change, no signiﬁcant
interaction between Group and CRF change was found.4. Discussion
This six-month randomised controlled trial investigated the
effect of exercise therapy on global brain volumes, hippo-
campal volume and cortical thickness in patients with
schizophrenia and healthy volunteers. In addition, cardio-
respiratory ﬁtness improvement achieved after six-months
of exercise was related to the brain changes. At baseline, in
line with a large body of evidence (Hulshoff Pol et al., 2002;
Shenton et al., 2001; Wright et al., 2000), we found smaller
cerebral and grey matter volumes, larger third ventricle
Table 1 Demographic and clinical characteristics of all exercise therapy (EX) and occupational therapy (OT) patients, EX
and life as usual (LaU) controls with baseline and follow-up MRI and compliance of at least 50% of 52 sessions.
Characteristic Treatment Statistic p
Patients (n=32) Controls (n=52)
EX
(n=18)
OT
(n=14)
EX
(n=25)
LaU
(n=27)
N N N N
Gender (male/female)a 14/4 12/2 18/7 18/9 1.93 0.59
CASH (schizophrenia/295.7/295.4)a 14/3/1 10/4/0 1.33 0.51
Parental education level (number of subjects
(educational level: 2,3,4,5,6,7))b, a
0,1,5,6,4,2 0,0,2,5,4,3 0,0,1,8,8,8 1,0,4, 8,10,4 13.70 0.55
Mean SD Mean SD Mean SD Mean SD
Age (year)c 28.5 7.3 31.1 8.0 29.5 8.3 28.4 7.0 0.44 0.72
Length (cm)c 178.9 10.9 178.6 5.6 180.5 10.6 176.6 9.8 0.71 0.55
Baseline weight (kg)c 85.8 18.8 85.2 20.1 78.2 16.6 74.6 12.4 2.28 0.09
Follow-up weight (kg)c 84.6 16.2 87.6 21.6 78.0 16.0 74.7 12.6 2.61 0.06
Baseline BMI (kg/m2)c 27.2 7.5 26.6 5.7 23.8 3.4 23.9 3.1 2.67 0.05
Follow-up BMI (kg/m2)c 26.7 6.2 27.4 6.3 23.8 3.3 23.9 3.0 3.23 0.03
Baseline VO2peak (ml/min/kg)
c 32.0 9.1 34.8 12.5 36.7 5.7 35.6 5.4 1.33 0.27
Follow-up VO2peak (ml/min/kg)
c 32.6 9.4 31.5 9.6 39.2 7.8 36.2 7.0 3.50 0.02
Baseline Wpeak (W)
c 221.6 43.5 247.9 57.9 265.6 54.3 247.4 54.9 2.41 0.07
Follow-up Wpeak (W)
c 247.6 40.9 236.1 52.6 275.2 68.3 243.7 57.9 1.94 0.13
Baseline WAIS Total IQc 84.8 12.0 99.1 22.1 111.8 13.2 105.8 14.0 12.10 o0.001
Baseline PANSS total scored, c 61.4 11.2 59.0 10.2 0.35 0.56
Follow-up PANSS total scored, c 54.8 12.1 58.9 9.8 1.05 0.31
Duration of illness (years)c 6.0 5.7 7.9 5.0 0.93 0.34
Hospitalisation until baseline (days)e 109.9 107.0 268.0 398.4 105.000 0.43
Baseline HEQ dose (mg/day)f, c 7.3 6.2 9.2 4.5 0.847 0.37
HEQ baseline to follow-up (mg)g, c 1489.1 1331.7 1821.2 975.9 0.61 0.44
Signiﬁcant differences at o0.05 level are presented in bold.
EX, OT, and LaU were compared (at baseline) on relevant demographic and clinical characteristics.
aChi-square were used.
bPsychosocial status, expressed as highest level of education of one of both parents according to Verhage, 1983.
cANOVA was used.
dPANSS total score: Positive and Negative Syndrome Scale assesses severity of psychosis.
eMann–Whitney U-tests was used.
fBaseline antipsychotic medication used in haloperidol equivalent in milligrams per day.
gAntipsychotic medication used between baseline and follow-up MRI-scans in haloperidol equivalent in milligrams.
T.W. Scheewe et al.680volume and thinning of most areas of the cortex in patients
with schizophrenia as compared to healthy controls. There
was no global brain volume, hippocampal volume and
cortical thickness change over time in patients and healthy
controls, who were randomised to the exercise therapy
group, as compared to those subjects who were randomised
to the occupational therapy or/life as usual groups. Never-
theless, overall improvement in cardiorespiratory ﬁtness
in the patients was associated with an increase in total
cerebral matter volume (or less volume decrease) and
attenuated increase (or even decrease) in lateral and third
ventricle volumes.
In addition, improvement in cardiorespiratory ﬁtness was
associated with cortical thickening (or less thinning) in the
left hemisphere in patients with schizophrenia as well as inhealthy controls. This suggests that moderate exercise
induces subtle changes in cerebral (grey matter) volume
most clearly (at least measurably) expressed in changes in
cortical thickness. The underlying mechanisms of brain
volume increases as a result of improved ﬁtness are still
unknown, but increased production of neurotrophic growth
factors, improved vascularisation, and improved energy
metabolism, all of which are of central importance in
neurogenesis (Cotman and Berchtold, 2002; van Praag,
2008, 2009) seem to play a role. Given the crucial role
exercise plays in neuronal plasticity, exercise therapy may
ameliorate brain abnormalities in schizophrenia.
Failing to ﬁnd an association between global brain
volumes and cardiorespiratory ﬁtness in healthy controls
could be related to the young mean age of the subjects
Table 2 Raw baseline and follow-up brain volumes in subjects with a minimal compliance of 50% of 52 sessions. In column I, unstandardised regression coefﬁcients b indicate
the brain volume change in patients relative to controls (i.e. main effect of group). Columns II and III provide the results from the interaction between group and intervention.
Column II shows the effect of exercise in controls only, and column III shows the additive effect of exercise in patients, corrected for sex, age and intracranial volume, in which
b represents the corrected volume difference in millilitres.
Outcome variables Patients (n=32) Controls (n=52) I II III
EX (n=18) OT (n=14) EX (n=25) LaU (n=27) Changes in patients
compared to controls
Effect of exercise in
controls only
Additive effect of
exercise in patients
Mean SD Mean SD Mean SD Mean SD b t p b t p b t p
Intracranial volume
Baseline 1520.8 139.4 1526.1 130.4 1506.8 135.6 1535.8 132.5
Follow-up 1519.4 139.8 1524.6 131.2 1507.4 135.9 1535.1 132.1 1.51 1.28 0.21 1.36 1.3 0.2 0.55 0.33 0.74
Total cerebrum
Baseline 1100.4 111.5 1104.7 96.9 1113.5 103 1134.8 99.4
Follow-up 1098.3 110.6 1102.1 100.1 1110.2 102 1134.3 97.1 1.18 0.33 0.74 2.72 0.89 0.37 2.62 0.53 0.6
Gray matter
Baseline 590.5 54.8 601 53.4 606.9 55.9 623.8 51.4
Follow-up 589.2 52.3 596.6 58.4 602.1 56.8 622.3 50 1.19 0.34 0.74 2.36 0.8 0.43 4.68 0.98 0.33
White matter
Baseline 509.8 66.5 503.8 60 506.6 52.7 511 56
Follow-up 509.1 67.3 505.6 59.1 508.1 52.2 512 55.9 0.01 0.004 1 0.36 0.2 0.84 2.07 0.71 0.48
Lateral ventricle
Baseline 16.89 7.92 17.88 9.9 14.39 8.1 14.64 9.04
Follow-up 17.09 7.96 18.21 10.42 14.77 8.32 14.43 8.91 0.47 1.25 0.22 0.57 1.79 0.08 0.68 1.3 0.2
Third ventricle
Baseline 0.84 0.42 0.93 0.49 0.58 0.28 0.7 0.28
Follow-up 0.84 0.39 0.96 0.56 0.59 0.29 0.67 0.27 0.05 1.47 0.15 0.03 1.05 0.3 0.05 1.16 0.25
Hippocampal volume
Baseline 8.01 0.8 7.99 0.7 8.07 0.66 8.13 0.87
Follow-up 7.93 0.82 8 0.64 8.06 0.64 8.06 0.85 0.07 1.28 0.2 0.06 1.26 0.21 0.14 2 0.05
All global brain volume measurements are expressed in mean and SD millilitres (ml). The real effect of exercise in patients (in ml) is calculated by adding b in column II (effect in controls)
to b in column III (additive effect in patients), signiﬁcant differences at o0.05 level are presented in bold.
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Table 3 The association between global brain volume change and CRF change (Wpeak), expressed as the unstandardised b
(in ml change/W change in Wpeak) for healthy controls, and the additive effects in patients.
Outcome variables All subject with two MRI-scans
Wpeak Change Wpeak Change
In healthy controls only Additive in patients
b t p b t p
Cerebral volume change 0.001 0.012 0.99 0.164 2.03 0.045
Gray matter change 0.019 0.302 0.763 0.159 1.911 0.059
White matter change 0.018 0.346 0.73 0.005 0.077 0.939
Lateral ventricle change 0.002 0.327 0.745 0.018 2.138 0.035
Third ventricle change 0.0003 0.661 0.51 0.0018 2.539 0.013
Hippocampal volume 0.0004 0.473 0.637 0.0005 0.443 0.659
Results expressed as b which represents the corrected brain volume difference in millilitres, corrected for gender, age, and
intracranial volume, signiﬁcant differences at o0.05 level are presented in bold.
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Figure 2 Scatterplot of relationship between cerebral
(a) change (gray matter change looks similar) and third
(b) ventricle volume change (lateral ventricle volume change
looks similar) (in ml, corrected for gender, age, IC-volume) and
CRF change in Wpeak for patients (squares) and healthy controls
(circles) with successful MRI-scans at baseline and follow-up.
T.W. Scheewe et al.682since not many brain changes occur in this age span (van
Haren et al., 2008b). In line with this explanation, a
randomised trial showed exercise to increase both cerebral
grey and white matter in sedentary older adults (Colcombe
et al., 2006) whereas exercise was only found to attenuate
the grey matter insula volume loss in young and mid-aged
adults (Gondoh et al., 2009).
Exercise therapy did not cause hippocampal volume to
increase in patients with schizophrenia nor in healthy controls.
Furthermore, hippocampal volume change was not related to
cardiorespiratory ﬁtness improvement. As far as we know, only
one MRI study examined the effects of exercise on brain
volumes in schizophrenia. Pajonk et al. (2010) found hippo-
campal volume increased in schizophrenia patients rando-
mised to 30 min of exercise three times weekly for three
months (12%) as well as in exercising healthy controls (16%
increase). In healthy elderly, after one year of exercise, the
anterior hippocampal volume was increased but the posterior
hippocampal volume was not affected by exercise (Erickson
et al., 2011). Thus, failing to ﬁnd an effect of exercise on
hippocampal volume in our study is unexpected, as there is
also robust evidence from animal studies that hippocampal
neurogenesis occurs as a result of exercise (van Praag, 2008).
The failure to ﬁnd a relationship between exercise/cardio-
respiratory ﬁtness improvement and hippocampal volume
possibly resulted from a low average weekly exercise fre-
quency performed by patients in our study compared to
Pajonk et al. (2010) (1.5 versus 2.6 exercise sessions weekly).
Differences in results may also have resulted from the
segmentation procedure which was used. Incorporation of
manual segmentation of hippocampal volumes, as used by
Pajonk et al. (2010), has shown to have higher reliability
compared to automated segmentation (Morey et al., 2009) as
used in the present study whereas automated procedures are
less time consuming, less costly, and have no inter-rater and
possibly lower intersession variability in a longitudinal design
(Niemann et al., 2000).
Some limitations should be considered when interpreting the
present results. First, due to drop out, poor quality MRI-scans,
Figure 3 Lateral (a) and medial (b) view depicting signiﬁcant association s between CRF improvement (Wpeak change in W) and
thickening (or less thinning) in the left hemisphere ,in large parts of the frontal, temporal and cingulate cortex.
Exercise therapy, cardiorespiratory ﬁtness and their effect on brain volumes 683and limited compliance, the ﬁnal sample size for exercise
therapy analyses was relatively small. The longitudinal exercise
therapy analyses were performed on 62% of the initial number
of included patients. Therapy adherence in schizophrenia
patients is problematic and needs to be improved. As shown
by two recent studies adherence to exercise regiments in
schizophrenia can be increased by incorporation of motiva-
tional techniques (Beebe et al., 2011, 2012). Second, exercise
frequency in the present study was limited namely one to two
1-h sessions weekly. This is lower than was previously incorpo-
rated by Pajonk et al. (2010). We suggest future studies
incorporate a higher, for example three sessions weekly,
exercise frequency. Third, this trial did not include a ‘treat-
ment as usual’ and therefore we were unable to examine the
differential effect of exercise therapy, occupational therapy
versus treatment as usual. No follow-up measurements were
performed in our study. Therefore, it remains unknown
whether patients continued to exercise after trial cessation
and whether improvement of cardiorespiratory ﬁtness and
associated global brain volumes and cortical thickness changes
lasted.
In summary, our study shows that improvement in cardi-
orespiratory ﬁtness is associated with cortical thickening in
most areas of the left frontal, temporal, and cingulate
cortices in schizophrenia patients and healthy controls.
Fitness improvement is also associated with an increase in
total cerebral matter volume increase (or attenuated
volume decrease) and a decrease in lateral and third
ventricle volume (or less increase) in the patients (not in
the healthy controls). However, exercise therapy, at least
when limited to 1–2 h weekly for six months as was the case
in our study, did not elicit signiﬁcant brain volume changes.
Further research is warranted to examine whether exercisetherapy can ameliorate brain abnormalities in schizophrenia
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